dapagliflozin for heart failure: a pooled analysis of dapa-hf and deliver
Published 2 years ago • 2.2K plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
6:27
pardeep jhund, esc 2022: dapagliflozin for heart failure, pooled analysis of dapa-hf and deliver
-
4:46
hfa 23: dapa-hf and deliver: kccq in patients with varying ejection fraction
-
3:50
dr. mcmurray discusses the dapa-hf trial of dapagliflozin in systolic heart failure
-
3:35
hf 2022: deliver extends benefits of dapagliflozin to the full spectrum of pts with hf
-
7:32
dapa-hf clinical trial i dapagliflozin i hfref
-
6:57
hfa 2020: dapagliflozin and diuretic use in patients with hfref in dapa-hf — dr alice m jackson
-
9:22
dr. scott solomon: dapagliflozin benefits patients with heart failure and kidney disease
-
7:03
dapa-hf: dapagliflozin’s hfref efficacy confirmed in nondiabetics
-
3:57
hfa 23: dapa-resist: dapagliflozin vs metolazone in patients with hf and diuretic resistance
-
0:55
further research studies of dapagliflozin
-
1:00
nurse webinars - dapagliflozin and heart failure
-
8:41
delivering the details on dapagliflozin in heart failure
-
8:15
sglt2 inhibitors and heart failure
-
6:53
hfa 2020: prospective analysis of dapa-hf — dr kieran docherty
-
13:07
nurse webinars - sglt2i - dapagliflozin and empagliflozin
-
10:57
best practices for starting sglt2 inhibitors in hfpef treatment
-
6:56
dapa hf study results
-
6:39
expert commentary: the dapa-hf and define-hf trials | lars rydén
-
4:45
esc 2022: the emperor-pooled trial: clinical benefits of sglt2i in heart failure | dr faiez zannad